Immunogenicity of an E. coli extract after oral or intraperitoneal administration: Induction of antibodies against pathogenic bacterial strains

International Journal of Immunopharmacology

Volumn 22, Issue 1, 2000, Pages 57-68

  Huber, M ^a   Baier, W ^a   Serr, A ^a   Bessler, W G ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Bacterial extract; Oral immunization; Parenteral immunization; Urinary tract; Vaccination

Indexed keywords

BACTERIAL VACCINE;

ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIUM; CELL CULTURE; ESCHERICHIA COLI; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; URINARY TRACT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ESCHERICHIA COLI; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C;

EID: 0033955973     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00064-8     Document Type: Article

References (14)

1. Bosch A., Benedi K.J., Pares R. Enhancement of the humoral immune response and resistance to bacterial infection in mice by the oral administration of a bacterial immunomodulator (OM-89). Immunopharmacol. Immunotoxicol. 10:1989;333-343.
2. Frey C., Obolenski W., Wyss H. Treatment of recurrent urinary tract infections: efficacy of an orally administered biological response modifier. Urol. Int. 41:1986;444-446.
3. Hachen H.J. Oral immunotherapy in paraplectic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial. J. Urol. 143:1990;759-763.
4. Tammen H. Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. Br. J. Urol. 65:1990;6-9.
5. Wybran J., Libin M., Schandene L. Enhancement of cytokine production and natural killer activity by an E. coli extract. Immunopharmacol. Immunotoxicol. 11:1989;17-32.
6. Bessler W.G., Beck P., Konetznick U., Loleit M., Sedelmeier E., Hoffmann P., Strecker M., Stöcklin S. Biological activities of bacterial surface components: immunogenicity and immunomodulatory properties of the bacterial extract OM-89. Arzneim.-Forsch./Drug Res. 41:1991;274-279.
7. Bessler W.G., Kleine B., Martinez A, Biesert L., Strecker M., Wiesmüller K., Metzger J., Jung G. Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunmodulators. Lung. 168:1990;707-715.
8. Sedelmeier E., Bessler W.G. Biological activity of bacterial cell wall components: immunogenicity of the bacterial extract OM-89. Immunopharmacology. 29:1995;29-36.
9. Baier W., Huber M., Bessler W.G. Oral immunization with a bacterial extract: induction of a specific humoral immune response. Immunobiol. 197:1997;338-339.
10. Baier W., Sedelmeier E.A., Bessler W.G. Studies on the immunogenicity of an E. coli extract after oral application in mice. Arzneim.-Forsch./Drug Research. 47:1997;980-985.
11. Bloemental R., van der Zee R., Rutten V.P.M.G., van Kooten P.J.S., Farine J.C., van Eden W. Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell response to heat shock protein (hsp)60 and hsp 70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatic arthritis (RA). Clin. Exp. Immunol. 110:1997;72-78.
12. Jahn S., Schwab J., Kiessig St, Lukowsky A., Huhnholtz K., Mehl M., Specht U., Grunow R., von Baehr R. Occurence of hybridomas producing multispecific IgM in human×(human-mouse) fusions with lymphocytes from different human immune compartments. Allerg. Immunol. 35:1989;271-277.
13. Bienenstock J., Befus A.D. Mucosal immunity. Immunology. 41:1980;249-270.
14. Langermann S., Palaszynski S., Barnhart M., Auguste G., Pinkner J.S., Burlein J., Barren P., Koenig S., Leath S., Jones C.H., Hultgren S.J. Prevention of mucosal E. coli Infection by FimH-Adhesin-based systemic vaccination. Sciences. 276:1997;607-611.